News
Market Data
Register to chat with like-minded investors on our interactive forums.
The current GALT market cap is 196.06M. The company's latest EPS is USD -0.6285 and P/E is -5.31.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -8.12M | -10.63M | -10.34M | -9M | -9.17M |
| Net Income | -8.58M | -10.7M | -11.53M | -9.18M | -14.04M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -13.6M | -13.44M | -23.44M | -30.18M | -38.35M |
| Net Income | -15.05M | -20.18M | -23.6M | -30.7M | -38.87M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 17.91M | 21.29M | 20.23M | 20.08M | 22.16M |
| Total Liabilities | 40.25M | 53.48M | 62.87M | 71.21M | 73.04M |
| Total Equity | -24.06M | -33.92M | -44.37M | -52.85M | -52.6M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 9.01M | 48.47M | 29.6M | 41.83M | 21.29M |
| Total Liabilities | 2.11M | 2.87M | 5.41M | 39.21M | 53.48M |
| Total Equity | 5.18M | 43.87M | 22.47M | 893k | -33.92M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -23.82M | -31.06M | -10.79M | -20.63M | -28.26M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | N/A | 10M | 10M | 20M | 30.03M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -10.18M | -10.85M | -20.6M | -24.31M | -31.06M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 15.38M | 50.08M | 263k | 36.81M | 10M |
| Market Cap | 196.06M |
| Price to Earnings Ratio | -5.31 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 11.11 |
| Price to Book Ratio | -6.42 |
| Dividend Yield | - |
| Shares Outstanding | 61.85M |
| Average Volume (1 week) | 262.69k |
| Average Volume (1 Month) | 289.91k |
| 52 Week Change | 60.91% |
| 52 Week High | 4.2684 |
| 52 Week Low | 1.28 |
| Spread (Intraday) | 0.18 (5.37%) |
| Company Name | Galectin Therapeutics Inc |
| Address |
701 s carson st carson city, nevada 89701 |
| Website | https://www.galectintherapeutics.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
